MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease

    K-L. Horne, R. Shoorangiz, L. Livingston, S. Grenfell, M. Almuqbel, B. Young, M. Pascoe, M. Livingstone, M. Macaskill, D. Myall, T. Pitcher, T. Anderson, J. Dalrymple-Alford, T. Melzer (Chrsitchurch, New Zealand)

    Objective: To characterise MRI-derived structural age-related brain health in Parkinson’s disease (PD) patients as a function of cognitive ability. Background: Normal ageing produces a stereotypical…
  • 2019 International Congress

    Relationship between striatal dopamine depletion and various non-motor symptoms in non-demented patients with Parkinson’s disease: a pilot study

    JY. Lee, H. Ju, K. Im, MY. Ahn, KY. Kwon (Seoul, Republic of Korea)

    Objective: We aimed to investigate associations of striatal dopamine uptake and various non-motor symptoms in non-demented patients with Parkinson’s disease (PD). Background: Dopamine transporter (DAT)…
  • 2019 International Congress

    Investigation of 531 cases of neuromelanin sensitive imaging, about its characteristics by disease

    K. Matsuura, Y. Ii, M. Maeda, K. Tabei, M. Umino, H. Tomimoto (Tsu, Japan)

    Objective: To investigate the utility of Neuro-Melanin sensitive MRI (NMI) by 3T MRI for diagnosis, the relationship and severity in Parkinson's disease (PD) and related…
  • 2019 International Congress

    Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson’s Disease: pilot PET data

    G. Pagano, H. Wilson, A. Mansur, S. Caminiti, R. Comley, H. Tsukada, R. Gunn, E. Rabiner, M. Politis (London, United Kingdom)

    Objective: In this study, we evaluated the density of Mitochondrial complex 1 (MC1), sigma 1 receptor (s1R) and Synaptic Vesicle protein 2A (SV2A) in early…
  • 2019 International Congress

    Potential involvement of the caudate nucleus in GBA-associated Parkinson’s disease

    MC. Ruppert, A. Greuel, M. Tahmasian, F. Maier, T. van Eimeren, K. Lohmann, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

    Objective: Multimodal functional assessment of striatocortical loop integrity in Parkinson’s Disease (PD) patients with and without GBA variants Background: Biallelic GBA mutations provoke the lysosomal…
  • 2019 International Congress

    Appropriateness of DAT Scan Ordering in a University Hospital Practice

    Z. Togher, S. Fullam, J. Britton, J. Duignan, R. Killeen, S. O'Riordan, M. Hutchinson (Dublin 4, Ireland)

    Objective: To examine the diagnostic utility (or misuse) of DAT scanning in a University Hospital practice – is there unnecessary utilisation of DAT scanning when…
  • 2019 International Congress

    Art du Deplacement (ADD)/Parkour therapy for people with Parkinson’s disease (PDP)

    M. Schwed, T. Getrost, K. Torchia, G. Yao (Pfungstadt, Germany)

    Objective: The purpose of this study was to transfer ADD training methods into safe training paradigms for PDP, and psychologically framed coping strategies for mood…
  • 2019 International Congress

    Clinical, genetic and radiological characterization of patients with movement disorders and basal ganglia calcification

    F. Arienti, G. Franco, E. Monfrini, A. Seresini, A. Di Fonzo (Milan, Italy)

    Objective: The aim of this study is to present a case series of patients affected by movement disorders and Fahr’s disease or Primary Familial Brain…
  • 2019 International Congress

    Validation of the ‘ecological momentary assessment’ (EMA) method as a tool for daily life monitoring in patients with Parkinson’s disease

    J. Habets, M. Heijmans, C. Herff, C. Simons, A. Leentjens, Y. Temel, M. Kuijf, P. Kubben (Maastricht, Netherlands)

    Objective: To validate the ‘ecological momentary assessment’ (EMA) method, also known as the ‘experience sampling method’ (ESM), as an instrument to monitor symptoms of PD.…
  • 2019 International Congress

    Unilateral leg tremor on sitting crossed-legged position as the initial manifestation of Parkinson’s disease

    I. Park, W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report an unusual case of initial manifestation of Parkinson's disease, which showed unilateral leg tremor on sitting crossed-legged position on…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 217
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley